Fluorodeoxyglucose positron emission tomography/computed tomography: a “one stop shop” for diagnosing polymyalgia rheumaticaBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.f7705 (Published 06 January 2014) Cite this as: BMJ 2014;348:f7705
- Michael S Hofman, physician in nuclear medicine and molecular imaging1
- 1Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia
In their clinical review Mackie and Mallen highlight that the diagnosis of polymyalgia rheumatica can be challenging and dependent on clinical experience and expertise, underscoring the need for better diagnostic algorithms.1 Given the various differential diagnoses, including occult infection, cancer, and myositis, patients are often subjected to an array of investigations before the diagnosis is established (often by exclusion), resulting in delayed diagnosis and costs associated …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial